RxDoctor Payments Data

Lee Gemma, MD

Clinical Cardiac Electrophysiology · Poland, OHNPI 1760699029

Payments from drug & device makers

$22,267in general payments, 2019–2025

Across 176 payments — averaging $126.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Impulse Dynamics (USA) Inc.$12K
  • Medtronic$8K
  • Boston Scientific$557
  • Biosense Webster, Inc.$516
  • Abbott$435
  • Atricure, Inc.$308
  • plus $246 from 4 others
$11,050in research payments, 2019–2025

Across 4 payments — averaging $2762.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$11K

What the payments were for

  • Speaking & faculty fees$1,50015%
  • Travel & lodging$1,44614%
  • Food & beverage$7,09171%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,267 in reported general payments places this provider in the 40th percentile of 159 clinical cardiac electrophysiology providers in Ohio.

See all clinical cardiac electrophysiology providers in Ohio

Medicare billing

Part B allowed, 2024
$185,710
Medicare patients
761
Services billed
2,505

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban145$158,728
XareltoRivaroxaban41$39,243
Colchicine45$2,745
Metoprolol Succinate149$2,399
Amiodarone Hcl82$1,523
Diltiazem 24hr Er (Cd)Diltiazem Hcl57$1,162
Flecainide Acetate24$636
SotalolSotalol Hcl37$575
Propafenone Hcl18$538
Carvedilol19$257
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide13$195
Atorvastatin Calcium13$188
Amlodipine Besylate36$185
Pantoprazole Sodium29$161
Furosemide40$146

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Poland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →